DPP9 and metastatic colorectal cancer: DPP9 is also considered to be a poor prognostic factor for metastatic colorectal cancer, and inhibiting the activity or expression of DPP9 can inhibit the viability of tumor cells and increase the sensitivity to antitumor drugs (Saso et al., 2020).